Evidence map›Paper›PMID 41072926›Full record

ArticleThe oncologist2025

Domains of prognostic awareness, quality of life, and psychological distress in patients with advanced cancer.

Hermioni L Amonoo, Joely Centracchio, Claire Greydanus, Mitchell W Lavoie, Emma P Keane, Joseph A Greer, Elizabeth C Lindenberger, Keri Brenner, Nneka N Ufere, Lara Traeger and 4 more

Abstract read
In one paragraph

Article in The oncologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hermioni L AmonooBrigham and Women's Hospital, Boston, MA 02115, United States.ORCID 0000-0001-9136-9644
Joely CentracchioUniversity of Miami, Department of Psychology, Miami, FL 33146, United States.
Claire GreydanusThe Warren Alpert Medical School of Brown University, Department of Medicine, Providence, RI 02912, United States.
Mitchell W LavoieUniversity of Massachusetts Chan Medical School, Department of Medicine , Worcester, MA 01655, United States.
Emma P KeaneBrigham and Women's Hospital, Boston, MA 02115, United States.
Joseph A GreerHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Elizabeth C LindenbergerHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Keri BrennerStanford University, Department of Medicine, Palo Alto, CA 94305, United States.
Nneka N UfereHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Lara TraegerUniversity of Miami, Department of Psychology, Miami, FL 33146, United States.
Jennifer S TemelHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Elyse R ParkHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Vicki JacksonHarvard Medical School, Harvard University , Boston, MA 02115, United States.
Areej El-JawahriHarvard Medical School, Harvard University , Boston, MA 02115, United States.

Funding

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation SurvivorsR37CA288557 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Hermioni L. Amonoo · 2024 to 2026
$2.1M
A Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients.K08CA251654 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI AMONOO, HERMIONI L. · 2020 to 2024
$1.3M
Doris Duke Foundation Clinician-Scientist DevelopmentNCI NIH HHS K08 CA251654NCI NIH HHS K08CA251654NCI NIH HHS R37 CA288557
6 · The paper itself

Abstract

introductionPrior studies have shown mixed findings regarding the relationship between prognostic awareness with quality of life (QOL) and psychological distress in patients with advanced cancer. Prognostic awareness is a multidimensional construct including a cognitive component (ie, the ability to understand one's life-limiting illness) and an emotional coping component (ie, the capacity to process terminal prognosis). Yet, it remains unclear which domains of prognostic awareness are associated with QOL and psychological distress. MATERIALS AND

methodsWe conducted a cross-sectional study of adults with metastatic solid tumors treated with noncurative intent at a single academic center from 11/2019 to 6/2022. We used the Prognostic Awareness Impact Scale (PAIS) to measure components of prognostic awareness, including the cognitive and emotional coping components. We used the Functional Assessment of Cancer Therapy-G and Hospital Anxiety and Depression Scale to measure QOL and psychological distress, respectively. Linear regression models were used to examine the relationship between the PAIS domains and patient-reported outcomes.

resultsWe enrolled 61.9% (632/1021) of eligible patients. Cognitive understanding of prognosis was not associated with QOL (B = -2.3, P = .114), anxiety (B = 0.7, P = .057), or depression symptoms (B = 0.4, P = .293). However, higher emotional coping with prognosis was associated with better QOL (B = 1.7; P < .001), lower anxiety (B = -0.6; P < .001), and depression (B = -0.3; P < .001).

conclusionPatients' emotional coping with their prognosis, rather than cognitive acknowledgment of their incurable cancer, was associated with QOL and psychological distress. Our findings underscore patients' ability to tolerate an accurate understanding of their prognosis and the critical need to incorporate effective coping strategies during prognostic discussions.

Indexed as

AwarenessNeoplasmsPsychological DistressQuality of LifeStress, PsychologicalAdaptation, PsychologicalAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrognosisacceptance of illnessadvanced cancercopingprognostic awarenesspsychological distressquality of life

Identifiers

PMID41072926
PMCPMC12605813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.